Archives
July 2009 (59)
- 29: Announcement…Follow Us On Twitter!!! (1)
- 10: News, Money and Drugs for Friday, July 10, 2009 (0)
- 10: What’s Hot in July – MJ Dies, but CTIC Lives! Sequenom Jobs Questioned and Cash for Genta (0)
- 10: Amid Protests at Paris Headquarters, Sanofi Prepares 1,300 for “Voluntary Layoffs” (0)
- 10: 270 Pink Slips for PPD Inc. (0)
- 10: BREAKING: Roche Starts Axing Genentech Employees, and Its Own (0)
- 10: Pfizer Rat Commercial Wins Big (0)
- 10: Job Docket for Friday July 10, 2009 (0)
- 09: News, Money and Drugs for Thursday, July 9, 2009 (0)
- 09: Natixis Bleichroeder Analyst Drops Merck (0)
- 09: Canada Reviewing Lantus Safety (0)
- 09: Uh-Oh, More Tamiflu-Resistant Swine Flu Cases Pop Up (0)
- 09: Injured Pfizer Researcher Comes Forward, Pfizer Won’t Release Health Records (1)
- 09: New Cell Therapeutics Presentation (1)
- 09: Amgen CEO Kevin Sharer Speaks! (0)
- 09: Portola Pharmaceuticals Gets $50M Upfront from Merck (Take the Poll) (0)
- 09: Job Docket for Thursday July 9, 2009 (0)
- 08: News, Money and Drugs for Wednesday, July 8, 2009 (0)
- 08: Not So Fast Denosumab (0)
- 08: CVS Pharmacy Also Getting Sued Over Zicam (0)
- 08: ARYx Nosedives After Anti-Clotting Drug Fails (0)
- 08: Dr. Reddy’s Growth on Hold (0)
- 08: Venture Update on Novacta; NanoBio and Zosano Raise Cash (0)
- 08: Amgen’s Denosumab Does Well, but Not Many Details on Side Effects (0)
- 08: Morning Job Docket for Wednesday, July 8, 2009 (0)
- 07: News, Money and Drugs for Tuesday, July 7, 2009 (0)
- 07: It’s Over: Novartis Ends NexMed Antifungal Deal (0)
- 07: Deal Roundup: Catalyst, OXiGENE, MorphoSys, Proteome Sciences, Lundbeck (0)
- 07: Financing Roundup: Viamet, Synergy, Novast, International Stem Cell Corporation (0)
- 07: Cell Therapeutics Note: OPAXIO/EMEA Meeting in September (Vote on OPAXIO!) (1)
- 07: 5AM, Excel Venture Close New Funds (0)
- 07: Near-Death Companies Get Cash: Genta, Somaxon (0)
- 07: Generic Drug Payoffs Illegal! (0)
- 07: Morning Job Docket for Tuesday, July 7, 2009 (0)
- 06: Sanofi’s Lantus Still Getting Scripts Despite Cancer Rumors (0)
- 06: News, Money and Drugs for Monday, July 6, 2009 (0)
- 06: Lawsuits Mounting for Zicam Maker Matrixx Initiatives (1)
- 06: Sequenom, Metabasis: The Cost of Mismanagement (4)
- 06: Santhera Swings Axe After Lead Drug Fails (0)
- 06: After Fed Seizure, Caraco Axes 350 Employees (0)
- 06: Burglars Steal Erection Drug from Bayer Headquarters (5)
- 06: A Light in the Lantus Darkness (0)
- 06: Morning Job Docket for Monday, July 6, 2009 (0)
- 03: Happy 4th of July!!!! (0)
- 02: The Other 2Q Top Ten…Part 2 (0)
- 02: News, Money and Drugs for Thursday, July 2, 2009 (0)
- 02: After All the Rumors, it’s J&J for Elan (Two Deals in Two Days!) (0)
- 02: European IPOs on the Way (0)
- 02: The 2Q Top Ten, Part 1 – The Complete List (0)
- 02: BREAKING: Acura and King Get Complete Response for Acurox (0)
- 02: Morning Job Docket for Thursday, July 2, 2009 (0)
- 01: News, Money and Drugs for Wednesday, July 1, 2009 (0)
- 01: New JV: Good for Maxygen Shareholders, Bad for Employees (0)
- 01: New Biotech Funds and News (0)
- 01: SEC Launches Sequenom Probe (0)
- 01: FDA Chantix Conference Call Today at 12:30PM EST, Will Discuss Side Effects (0)
- 01: BREAKING: FDA Issues Statement on Sanofi’s Lantus (0)
- 01: Acorda, Biogen in Ex-U.S. Deal for Fampridine-SR; No U.S.? (0)
- 01: Morning Job Docket for Wednesday, July 1, 2009 (0)
June 2009 (178)
- 30: AMAG’s Feraheme Gets Approval, So Does This Answer Our Question About the FDA? (1)
- 30: News, Money and Drugs for Tuesday, June 30, 2009 (0)
- 30: Murderers: Zoloft, Accutane Made Me Do It (2)
- 30: UPDATE: FDA Panel Urges Vicodin, Similar Drugs, Pulled from Market (2)
- 30: Everyone’s Interested in Demerol (0)
- 30: Another Delay at the FDA…What’s Going On? (5)
- 30: BREAKING: Panel Says Tylenol Max Daily Dose Should be Reduced (0)
- 30: Jerini Can’t Sell Preclinical Assets, Axes 45 Employees (0)
- 30: Cell Therapeutics Added to Russell Indexes, Shares Still Down (1)
- 30: Hyperion Raises $60 Million, ProCertus Gets $2.1 Million (0)
- 30: Sanofi Shutting Plants, but No Layoffs; Employees Must Axe Themselves? (1)
- 30: Morning Job Docket for Tuesday, June 30, 2009 (0)
- 29: Lantus Leak Likely Never to be Found, Meanwhile Sanofi Seeks Advice (0)
- 29: News, Money and Drugs for Monday, June 29, 2009 (0)
- 29: Ex-Genentech CFO Joins Facebook – IPO Soon? (0)
- 29: Yet Another Tysabri Patient with PML – This Makes #10 (0)
- 29: First Case of Tamiflu-Resistant Swine Flu (0)
- 29: Is Adam Feuerstein Hurting ‘The Street’s Credibility, and Stock? (0)
- 29: Solvay Progressing with Sale (0)
- 29: BB BIOTECH VENTURES Closes $95 Million Fund (0)
- 29: Morning Job Docket for Monday, June 29, 2009 (0)
- 28: Cell Therapeutics’ OPAXIO: Hype or Truth? (13)
- 28: Last Week’s Top Ten: Sanofi Tanks, Acura Up in the Air, MJ Dies, and Dendreon/Madoff? (0)
- 28: BREAKING: Novartis in Partial Buyout Talks with Elan (0)
- 26: Lantus Docs Send “Concerns” to EMEA, “Urgent” Call for Further Research into Cancer Connection (0)
- 26: News, Money and Drugs for Friday, June 26, 2009 (0)
- 26: Cell Therapeutics: The MJ of Biotech? (12)
- 26: Pharma Reps Not Necessarily Needed, but Medical Science Liaisons are Golden (1)
- 26: Novo Nordisk Settles Lawsuit Over Sales to Saddam Hussein-ruled Iraq (0)
- 26: FDA Missed Zicam Smell Loss, and This Guy’s 2004 Website (2)
- 26: Sanofi Tanks Further…Analysts Downgrade on Possible Lantus Cancer Risk (0)
- 26: Morning Job Docket for Friday, June 26, 2009 (0)
- 25: RIP: Michael Jackson, Farrah Fawcett (0)
- 25: More Dendreon and Madoff Ties, Plus Cougar Biotechnology? (2)
- 25: Doc’s Words on Lantus Spook Investors, Sanofi Sinks (1)
- 25: TARIS Biomedical Pulls in $15 Million (0)
- 25: PharmaVendor – Every Biotech and Pharma Vendor in One Place! (0)
- 25: Morning Job Docket for Thursday, June 25, 2009 (0)
- 24: News, Money and Drugs for Wednesday, June 24, 2009 (0)
- 24: Hemispherx Biopharma Annual Stockholder Meeting Comes and Goes, but Still No FDA Update on Ampligen (1)
- 24: Financing Roundup: Lumavita, Zymeworks, Intrexon (0)
- 24: Pixantrone NDA Submission Done, Opaxio Update… (1)
- 24: More Sanofi…R&D Reorganization and Announcements Coming (0)
- 24: Morning Job Docket for Wednesday, June 24, 2009 – Dialysis Services, PharmaScouts, Duke University (0)
- 23: News, Money and Drugs for Tuesday, June 23, 2009 (0)
- 23: Acura Pharmaceuticals: FDA Backed Up or Complete Response Coming? (0)
- 23: More Dendreon Scandal Theories from DeepCapture: The Madoff Exemption (0)
- 23: New Case Might Limit Whistleblower Lawsuits Against Biotechs (0)
- 23: Chroma Therapeutics in Deal with GSK, Raises $24 Million (0)
- 23: How Twitter Crashed Matrixx; Also, SEC Wants Zicam Info (0)
- 23: Morning Job Docket for Tuesday, June 23, 2009 (0)
- 22: News, Money and Drugs for Monday, June 22, 2009 (0)
- 22: Another Tysabri Patient with PML – This Makes #9 (0)
- 22: The Street’s Adam Feuerstein’s Prediction: HEB Will Pull Ampligen NDA (0)
- 22: D-Day for Denosumab: August 13th… (0)
- 22: Pink Slips at Sanofi Next Week? (0)
- 22: Rx Help on the Way, $80 Billion in Savings for Seniors (0)
- 22: The Only Job Guide You Will Ever Need… (0)
- 22: Morning Job Docket for Monday, June 22, 2009 – PharmaScouts, Needham & Co., Monsanto… (0)
- 21: The Top Ten: Dendreon, Novartis Drama, More Cell Therapeutics, Sanofi Rumors… (0)
- 20: ABC’s John Stossel vs. Novartis’ Holly Waters: You Tell Us Who’s Right! (9)
- 20: Matrixx Initiatives (of Zicam Fame): These Guys Sound Pissed… (1)
- 19: News, Money and Drugs for Friday, June 19, 2009 (0)
- 19: Dendreon: Behind the (Financial) Curtain…The Mafia??? (2)
- 19: Venture Update: Proteolix Presents Preclinical Data (0)
- 19: Morning Job Docket for Friday, June 19, 2009 – PharmaScouts, PRTM, Vertex (0)
- 18: News, Money and Drugs for Thursday, June 18, 2009 (1)
- 18: European Pharmas: What Recession??!! (0)
- 18: BREAKING: Matrixx Had 800+ Reports of Zicam Side Effects (0)
- 18: Sanofi’s Viebacher: If You Can Partner, Why Acquire? (0)
- 18: Does this Zicam Stuff Really Mess Up Your Nose? (1)
- 18: The Street: I’m Shorting HEB and CTIC (6)
- 18: Another Pharma Movie, This One From Reese Witherspoon (0)
- 18: PharmaVendor: Search Vendors by Therapeutic Area, Expertise and Geography (0)
- 18: Morning Job Docket for Thursday, June 18, 2009 – PharmaScouts, Astellas, Cubist (0)
- 17: News, Money and Drugs for Wednesday, June 17, 2009 (0)
- 17: Rumors: Who Will Sanofi Buy? (0)
- 17: Viehbacher Says Sanofi to Donate 100M Doses of Swine Flu Vaccine (Novartis’ Vasella Still Says No) (0)
- 17: Deerfield Believes in Arena Pharmaceuticals, Lines up $100M (0)
- 17: Morning Job Docket for Wednesday, June 17, 2009 – PharmaScouts, King, Teva… (0)
- 16: Pregnant Novartis Rep Gets Axe, Now ABC’s John Stossel Getting Hate Mail (And It’s Not Regarding the Pornstache) (5)
- 16: News, Money and Drugs for Tuesday, June 16, 2009 – Zicam Warning, Arzerra Setback, Cell Therapeutics’ Debt Offer… (1)
- 16: Watson Axes 275 Employees (0)
- 16: BREAKING: 14-1 in Favor of Krystexxa (0)
- 16: Savient Update Soon…What Do YOU Think? (0)
- 16: IguanaBio is Listening!! Take Our Poll! (0)
- 16: Genzyme Plant Shut Down Due to Virus Contamination, Shares Tank (0)
- 16: Morning Job Docket for Tuesday, June 16, 2009 – PostDocs, Vertex, Cubist… (0)
- 15: Proteolix: Developing the Next Velcade (Plus the Multiple Myeloma Pipeline) (0)
- 15: News, Money and Drugs for Monday, June 15, 2009 (0)
- 15: It’s On! Pfizer Sues Mylan Over Lipitor Generic Launch (0)
- 15: Germany’s GANYMED Goes Gastrointestinal… (0)
- 15: Boehringer Ingelheim, Ipsen Get Deals Done (0)
- 15: Pfizer, GSK: The Race for Emerging Markets (0)
- 15: Looking for a Job? You Need This! (0)
- 15: Morning Job Docket – Monday, June 15, 2009 (0)
- 14: Novartis to Poor: No Free Swine Flu Vaccine For You!!! (Take the Poll!) (0)
- 14: The Top Ten!!! Merck Pink Slips, Denosumab Fate Awaits, Pixantrone Potential and That Guy from RoadHouse… (0)
- 13: Cell Therapeutics Note: This Week’s News, Pixantrone Competition and Market Analysis (3)
- 13: What’s Hot in June…Ampligen Delays, Pfizer/Wyeth, Solvay Fizzles, and More… (0)
- 13: Another Tysabri Patient with PML… (0)
- 12: News, Money and Drugs for Friday, June 12, 2009 (0)
- 12: Venture Udpates: Arete Therapeutics, DuoCort (0)
- 12: Elan Board Shakeup? Get Ready for Jack vs. Kelly… (0)
- 12: Novartis Beats Competition, Makes First Swine Flu Vaccine Batch (2)
- 12: Novartis CEO Dan Vasella Talks Patents, Patients and Pipeline… (2)
- 12: Morning Job Docket – Friday, June 12, 2009 (0)
- 11: News, Money and Drugs for Thursday, June 11, 2009 (0)
- 11: Oscient Gives 180 Employees the Boot; Screw It, Let Products Sell Themselves (0)
- 11: Obama “Enamored” with Venture Capital Equals More SBIR’s (0)
- 11: Post-Biosimilars? Lawsuits!! (2)
- 11: Irish Drama: Elan CEO Expects Deal Soon, AGI Looks for Options (0)
- 11: Search Vendors by Therapeutic Area, Expertise and Geography – All at PharmaVendor (0)
- 11: Morning Job Docket – Thursday, June 11, 2009 (0)
- 10: News, Money and Drugs for Wednesday, June 10, 2009 (0)
- 10: 16,000 Pink Slips at Merck Post-Merger (1)
- 10: Bayhill Therapeutics Gets $25M Upfront from Genentech (1)
- 10: Endo Axes Indevus Employees (0)
- 10: Pfizer to Goldman: This Off-Patent Drug Market is Big! (1)
- 10: Amgen Expects Denosumab Panel, Confirms Safety Concerns (1)
- 10: Latest Financings: NanoString, Savara, Pique (0)
- 10: Biovays – Biomarkers for Targeted Drug Development (0)
- 10: Morning Job Docket – Wednesday, June 10, 2009 (0)
- 09: The IguanaBio Discussion Board is Live! (0)
- 09: News, Money and Drugs for Tuesday, June 9, 2009 (0)
- 09: Amylin CEO at Goldman Sachs: LAR Will Be Best in Class (0)
- 09: ADA: Doc Says Lira Thyroid Issues “Unlikely” to Affect Humans (0)
- 09: Research Update: BioMarin Reports Phase 1 PEG-PAL Data (0)
- 09: Morning Job Docket – Tuesday, June 9, 2009 (0)
- 08: Trius Therapeutics Venture Update, Lead Therapeutics Gets $3M (0)
- 08: News, Money and Drugs for Monday, June 8, 2009 (0)
- 08: Arena CEO Jack Lief Speaks, Says Potential Partners Not Interested Until Blossom Data (0)
- 08: Waxman Pushes Biosimilars to Obama, Personally (0)
- 08: Jake Gyllenhaal to Star in Viagra Salesman Movie (1)
- 08: CSL, Talecris Deal Scrapped (0)
- 08: More Hemispherx Drama (1)
- 08: Pure Science Play: Pharma Venture Arms Believe in Aileron, $40M in Series D (0)
- 08: The Biotech Job Hunt – Essential Advice!!! (0)
- 08: Morning Job Docket – Monday, June 8, 2009 (0)
- 05: This Week’s Top Ten Comes Early!!! (1)
- 05: Belgian Source: Little Interest in Solvay (0)
- 05: Morning Job Docket – Friday, June 5, 2009 (0)
- 04: News, Money and Drugs for Thursday, June 4, 2009 (0)
- 04: Hemispherx Biopharma -There Must be a Bull Somewhere! (3)
- 04: J&J Confirms Priligy for Premature Ejaculation on Track for U.S. Filing (0)
- 04: Today’s Rumors: More Elan Hype, Zeltia Partnership on the Way (0)
- 04: Update: Anadys Partnering Out, Raises $16M to Stay Afloat (0)
- 04: Anadys Axes 20 Employees, No Word on Partnering Progress (0)
- 04: Pfizer/Wyeth Merger on Track – Maybe? (1)
- 04: Morning Job Docket – Thursday, June 4, 2009 (0)
- 03: News, Money and Drugs for Wednesday, June 3, 2009 (0)
- 03: Breaking: Adolor Swings Axe – 45 Employees Gone! (0)
- 03: Pfizer’s Palladia First Cancer Drug for Pooches (0)
- 03: IguanaBio Layoff Series – The Job Hunt is On!!! (1)
- 03: Novartis’ Daniel Vasella Might Say “No Thanks” to Alcon (0)
- 03: Low on Cash, Cell Therapeutics Presents More Data (Opaxio Write-up??) (66)
- 03: CRO Value – 10% Rebate for all Biovays Service Agreements, Only Through IguanaBio! (0)
- 03: Morning Job Docket – Wednesday, June 3, 2009 (0)
- 02: CafePharma Posts to be Used Against Schering-Plough (1)
- 02: News, Money and Drugs for Tuesday, June 2, 2009 – Icahn Wins, More CTIC (0)
- 02: Nanogen Gives 89 the Boot – Plus Arena and Valeant (0)
- 02: Financings: biOasis, miRagen, Versartis, OPKO (0)
- 02: Why Did The FDA Approve Vanda’s Fanapt, but Not J&J’s Xarelto? (0)
- 02: Millennium Pharmaceuticals CEO: Smaller Drug Companies “Delusional” (0)
- 02: CEO Street-Cred So-so? You Can Still Raise Cash Says Asst Prof!! (1)
- 02: Concert Pharmaceuticals in $1B Deal with GSK (0)
- 02: Manufacturing Advice for Optimal Drug Development (0)
- 02: Morning Job Docket – Tuesday, June 2, 2009 (0)
- 01: The Gloves Are Off – Die Hard CTIC Fans Strike Back, Plus Management Has Its Say… (6)
- 01: The Street’s Adam Feuerstein Slams CTIC, Pixantrone Data (27)
- 01: News, Money and Drugs for Monday, June 1, 2009 – Plus ASCO Final Roundup Part 2 (0)
- 01: MannKind’s Afresa – The Bulls and The Bears (1)
- 01: Pixantrone Data Skyrockets CTIC (1)
- 01: ASCO Final Roundup Part 1 (0)
- 01: ARCA Biopharma Gets Complete Response Letter for Gencaro!! (0)
- 01: Bristol-Myers Not in Talks with Elan!! (0)
- 01: Job Docket for Monday, June 1, 2009 (0)
- 01: Essential Tips for the Biotech Job Hunt (0)
May 2009 (171)
- 31: ASCO Weekend Roundup Part 2 (0)
- 31: ASCO Weekend Roundup Part 1 – Focus on BiPar (0)
- 31: Last Week’s Top Ten – Hamburg Rules, Sawyze Slipping, Genta Gaining… (0)
- 30: European Biotechs – Always a Bridesmaid, Never a Bride (0)
- 29: News, Money and Drugs for Friday, May 29, 2009 – Curagen Sold! (0)
- 29: Catalyst Sinks, but This Guy’s Yacht Doing Just Fine (1)
- 29: ASCO Starts Today, Secrets Revealed, Media Going Crazy (0)
- 29: Layoffs!!! AP Pharma, Reddy’s (Not) and What’s Going on at Metabasis? (0)
- 29: Job Docket for Friday, May 29, 2009 (0)
- 28: Genta’s Tesetaxel – Hype or Truth? (1)
- 28: News, Money and Drugs for Thursday, May 28, 2009 – FDA Rejects J&J’s Xarelto (0)
- 28: More Pfizer: Fly in Jeff Kindler’s Gulfstream V for $64,750,000!! (0)
- 28: More ASCO Watch, Plus The Street’s Adam Feuerstein Talks ASCO (2)
- 28: UK’s BIA Says Government Ignoring Cash Pleas, Not Listening (0)
- 28: Xeloda Can Give You a Clean Get Away (0)
- 28: FTC and CSL – The Fight for Talecris is On (0)
- 28: Exelixis Gets $140M Upfront from Sanofi in PI3K Deal (0)
- 28: The OSMOS Advantage for Clinical Trials in Emerging Markets (1)
- 28: Job Docket for Thursday, May 28, 2009 (0)
- 27: Venture Updates – HemaQuest, Cornerstone Pharmaceuticals (0)
- 27: News, Money and Drugs for Wednesday, May 27, 2009 – Icahn, Eastbourne Victorious (0)
- 27: Metabasis Layoffs – Rumor Confirmed in Wee Hours (0)
- 27: More Hamburg, Speaking of Renaissance Technologies…Acorda, Amylin, Pfizer (1)
- 27: Concerns Over Genmab’s Arzerra!! Shares Plunge!! (0)
- 27: Today’s the Big Day for Amylin, Icahn (0)
- 27: Seeking Alpha’s Top ASCO Picks (0)
- 27: Biovays – Biomarkers for Drug Discovery & Development (0)
- 27: Job Docket for Wednesday, May 27, 2009 – Jobs, Jobs, Jobs!!! (0)
- 26: Metabasis Swings Axe After Long Weekend – Down to 7 Employees (0)
- 26: News, Money and Drugs for Tuesday, May 26, 2009 (0)
- 26: ASCO Watch 2009 – Celgene, MediGene, TRACON, Ascenta, Sunesis, Memgen (0)
- 26: Hamburg’s Husband Top Guy at Renaissance, Must Divest (0)
- 26: MAP Pharmaceuticals Skyrockets After Migraine Trial Success, Exits Graveyard (0)
- 26: Amgen Picks up Cytokinetics Option, Pays $50M Upfront (0)
- 26: Streamlining Manufacturing, Faster FDA Filing, BioPharm Process Associates (0)
- 26: Job Docket for Tuesday, May 26, 2009 (0)
- 24: Financing Roundup – Avid Radiopharmaceuticals, Sagent Pharmaceuticals, Vical (0)
- 24: Last Week’s Top Ten: Kindler Talks Wyeth, ARCA Makes News and Lots of Interest in Vatalanib (0)
- 23: Weekend Job Docket for May 23-25, 2009 (0)
- 22: What’s Coming Up on IguanaBio???!!! (0)
- 22: News, Money and Drugs for Friday, May 22, 2009 – Aastrom Stops Trial… (0)
- 22: ARCA Biopharma Swings Axe – 40 Employees Gone (0)
- 22: J&J’s Teen Drama (Advertisement) a Web Success! (0)
- 22: Cubist Up to Bat? (0)
- 22: BioPharm Process Associates: Premium Manufacturing Advice = Faster FDA Filing (0)
- 22: Job Docket for Friday, May 22, 2009 (0)
- 21: News, Money and Drugs for Thursday, May 21, 2009 – Genzyme, Plus ASCO Watch (0)
- 21: Cell Therapeutics Responds… (4)
- 21: Johnson & Johnson Buying Cougar for $1B Cash! (0)
- 21: ARCA Updates – What’s Up (Errr, Down)? (0)
- 21: ARCA Biopharma Layoffs!!! (4)
- 21: Why is ARCA Biopharma Down Today? (1)
- 21: Novartis, Neutec Deal – Lawyers, CFO Accused of Insider Trading (0)
- 21: Pfizer’s Jeff Kindler Speaks with CNBC, Talks Wyeth and Free Drugs (1)
- 21: Start-up Clovis Oncology Raises a Massive $145M from Domain, NEA (0)
- 21: Conducting Clinical Trials in Emerging Markets Just Got Easier – The OSMOS Edge (0)
- 21: Job Docket for Thursday, May 21, 2009 (0)
- 20: What’s Hot in May – Facet Biotech, Genasense’s Last Stand, PEG-PAL, Etc… (1)
- 20: News, Money and Drugs for Wednesday, May 20, 2009 – Isis Concerns… (0)
- 20: OrbiMed Bets $8M on Gleevec, MDV3100 Inventors (0)
- 20: Generics, Emerging Markets and More Ratiopharm Rumors (0)
- 20: China’s Jinsite Gets $15M from Kleiner Perkins (0)
- 20: Titan Pharmaceuticals Exiting Graveyard, Slowly (0)
- 20: Flexibility, Innovation – Biovays Leads the Way in Biotech CROs (0)
- 20: Job Docket for Wednesday, May 20, 2009 (0)
- 19: The Pixantrone “Ghost Post”…Plus Today’s Safety Data (Our Take) (7)
- 19: News, Money and Drugs for Tuesday, May 19, 2009 – Elton John Speaks at BIO!!! (1)
- 19: Solvay Makes Deals with Lipocine, HUYA; None with Sanofi or Takeda (Yet) (0)
- 19: More Arena Pharmaceuticals: Derek Lowe Seriously Upsets (Overreacting?) Shareholders (4)
- 19: We Have a New Leader: Margaret “Peggy” Hamburg Confirmed FDA Chief (1)
- 19: Medtronic Adds to Layoff Massacre: 1,800 Jobs Gone! (1)
- 19: An Exhausted Genasense Nears Its End… (3)
- 19: Job Docket for Tuesday, May 19, 2009 (0)
- 18: News, Money and Drugs for Monday, May 18, 2009 – BIO, ASCO & Some Other Stuff (0)
- 18: Pixantrone Data…by Popular Demand (3)
- 18: Biotech Bloodbath – Redpoint, Nucryst Swing Axe (0)
- 18: Money, Deals, Etc…Takeda, Xori, Sciele (Some Others Too) (0)
- 18: Legal Updates: Onyx Mad at Bayer, Vioxx Nurses Paid Nicely (0)
- 18: Europe’s Alliance Boots Puts on Boot, 1,500 Jobs Gone; KKR Doing OK (0)
- 18: Job Docket for Monday, May 18, 2009 (0)
- 17: Cell Therapeutics’ Pixantrone: Hype or Truth? (11)
- 17: Last Week’s Top Ten – Pixantrone No Match for Patrick Swayze, Facet Biotech, Solvay Rumors Ongoing (0)
- 16: Weekend Job Docket for May 16-17, 2009 (Because It Just Might Come To This) (0)
- 16: Solvay Update!!! Sale May Take Time, Analysts Now Mixed, Family Holding Out!!! (0)
- 15: News, Money and Drugs for Friday, May 15, 2009 – Salix, Debio’s Vapreotide Gets Thumbs Down (0)
- 15: ASCO Watch 2009 – Xencor, Amgen, Boehringer Ingelheim, Entremed, BioCryst, ZIOPHARM (0)
- 15: SkyePharma Not Joking, Swings Axe at Swiss, French (0)
- 15: Latest Financings and Deals – Cempra, GlobeImmune, BioTime (0)
- 15: Arrivederci!! Cell Therapeutics Completes Axing of 56 in Italy, D-Day Starts Monday (0)
- 15: Essential Advice for Timely and Efficient Manufacturing of Your cGMP Product (1)
- 15: Job Docket for Friday, May 15, 2009 (0)
- 14: Cell Therapeutics Shareholders to Adam Feuerstein: You’re a D@$*!!! (11)
- 14: News, Money and Drugs for Thursday, May 14, 2009 (1)
- 14: ASCO Abstracts Are Up!!!! (1)
- 14: Nigeria Settles Multibillion Dollar Pfizer-Trovan Case for $75M (1)
- 14: Amylin vs. Icahn – The Battle Rages On… (0)
- 14: Pfizer: Free Viagra, Lipitor for Pink Slips (3)
- 14: Facet Biotech: Daclizumab for Multiple Sclerosis, Hype or Truth? (0)
- 14: Let OSMOS Streamline Your Global Clinical Trials – Speed, Compliance, Reliability. (0)
- 14: Job Docket for Thursday, May 14, 2009 (0)
- 13: News, Money and Drugs for Wednesday, May 13, 2009 (0)
- 13: Financings and More Venture Updates – Metabolic Solutions, Addrenex, Artisan (1)
- 13: Solvay Throwing Curve Balls on Rumors, J.P.Morgan Thinks Takeda? (1)
- 13: Venture Update: Follica Gets a CEO (Plus, Dear Daphne) (3)
- 13: Medicine’s Company Halts Trial, Shares Tank!! Still Hope? (1)
- 13: Using Biomarkers for Drug Development? (0)
- 12: News, Money and Drugs for Tuesday, May 12, 2009 (0)
- 12: Some New Biotech Funds, Some Giving Up (0)
- 12: ASCO Watch 2009 – Eli Lilly, Medivation, Abraxis, Oncolytics Biotech, OXiGENE, Genmab (0)
- 12: More Pfizer: 40,000 Layoffs Not Cheap, Wyeth Gets Short Stick, Stock Price Seeing Lifeline? (2)
- 12: Today’s Layoffs (and Graveyard) – Neurogen, Progenics, Capstone Therapeutics (0)
- 12: Cell Therapeutics – Pressure Building, ASCO Coming Soon, The Bear View (8)
- 12: Job Docket for Tuesday, May 12, 2009 (0)
- 11: Today’s Financings, Deals and Venture Updates… (0)
- 11: News, Money and Drugs for Monday, May 11, 2009 (0)
- 11: Ready for the Plan B TV Commercial? (1)
- 11: MannKind Axes 100, German Factory Workers Next to Go (?), Afresa Deal Coming (0)
- 11: More Pfizer: Kindler Speaks! Advises on Drug Research Success… (3)
- 11: Legal Updates: Pfizer’s Nigerian Dilemma Endless, Novo Nordisk and Saddam Hussein? (0)
- 11: Genzyme/Bayer Campath Deal Results in 120 Axes (1)
- 11: ASCO Watch 2009 – OncoGenex, GSK, Immunomedics, Poniard, Cyclacel (1)
- 11: Job Docket for Monday, May 11, 2009 (0)
- 10: Last Week’s Top Ten: CTIC Dethrones Swayze, Arena CEO Speaks, Elan Revisited, Plus Biomarin’s PEG-PAL (2)
- 08: News, Money and Drugs for Friday, May 8, 2009 (1)
- 08: Allergan Axes 360 from Manufacturing Plant, Northfield Does Same (0)
- 08: More Merck…Doctor from Fake Journal Speaks, Cervarix vs. Gardasil and Victory in California (0)
- 08: Ardea Biosciences Gives Boot to Almost Half Workforce (0)
- 08: Financing, Offering and Deal Roundup: Dendreon, Tokai Pharma, Cornerstone Therapeutics (0)
- 08: BioPharm Process Associates: Accelerating Products Through FDA and Into the Marketplace (0)
- 08: Job Docket for Friday, May 8, 2009 (0)
- 07: Sex & Drugs Today: No Viagra on Daytime TV; Androgel, Testim May Spread to Kids, Enlarge Genitals (1)
- 07: OOPS!!! GSK Offers 50% Rx Discount to Uninsured, Then Says Press Release a Mistake (0)
- 07: Today’s Rumor: Oscient on Auction Block, Shares Rise, Deal Close? (0)
- 07: More Cell Therapeutics: A Wild Ride, OPAXIO on YouTube, and a Second Fansite? (0)
- 07: The OSMOS Advantage for Conducting Clinical Trials in Emerging Markets (0)
- 07: Job Docket for Thursday, May 7, 2009 (0)
- 06: News, Money and Drugs for Wednesday, May 6, 2009 (0)
- 06: Bloodbath Continues: DURECT Hands Out 41 Walking Papers (0)
- 06: Paula Abdul No Longer Addicted to J&J’s Duragesic (0)
- 06: Charles River Laboratories Axes 3% of Workforce (0)
- 06: Biovail Axes 50 Employees (Oh Yeah, And Also Buys Wellbutrin Rights for $510M) (0)
- 06: Dendreon NOT Reducing Headcount, Seeks to Raise Cash for Provenge (0)
- 06: Acorda’s Fampridine: NDA Accepted, Priority Review, Hype or Truth? (1)
- 06: The Next Big Thing: Biomarkers and Specialized Models (0)
- 06: Job Docket for Wednesday, May 6, 2009 (0)
- 05: News, Money and Drugs for Tuesday, May 5, 2009 (0)
- 05: Axe Swingin’ in Full Gear: Neurocrine Says Bye to 60 Employees (0)
- 05: Germany’s Evotec Shows 45 Employees Exit Sign; Renovis Subsidiary Dead, in Graveyard (0)
- 05: Latest Financings…Calistoga, Kamada, NABsys (0)
- 05: Nycomed Sale Scrapped! Roflumilast Partner Announcement by June? (0)
- 05: Sequenom Lawsuits Mounting, Company Crisis Looms (1)
- 05: Job Docket for Tuesday, May 5, 2009 (0)
- 05: Cell Therapeutics Makes Pixantrone Available in EU, NDA Filing Completion on Target for End of 2Q (0)
- 04: Laid Off Sales Reps Have Resource at AfterPharma (0)
- 04: News, Money and Drugs for Monday, May 4, 2009 (0)
- 04: Amylin Axes 200 Reps! (0)
- 04: Some Hope for Struggling UK Biotechs (0)
- 04: Discovery Labs Hands Out 24 Pink Slips (1)
- 04: Cell Therapeutics, Pixantrone Gets Fan Site…Obsession Continues (19)
- 04: Venture Update – Oxagen Alive! (0)
- 04: Ironwood Pharmaceuticals and Spain’s Almirall in $95M Deal for Constipation Drug (0)
- 04: Job Docket for Monday, May 4, 2009 (0)
- 03: Last Week’s Top Ten: Sequenom Screws Up, Layoff Rumors and Patrick Swayze (Again) (0)
- 02: BIO CEO Three Months Later: Did We Talk Too Much S@!t? (1)
- 02: More Cell Therapeutics: OPAXIO vs. Pixantrone, The Race is On (8)
- 02: Weekend Job Docket for May 2-3, 2009 – Genzyme, Sanofi, iBanking (0)
- 01: Northfield Labs’ Rented Analyst: “We Consider the Stock a Lottery Ticket” (0)
- 01: ASCO Watch 09 Update: Abstracts, Allos, Immunogen, Medarex (2)
- 01: Got a Story for Us? Gossip, Rumors? Know Something? (0)
- 01: Arena Pharmaceuticals CEO Defends Weight Loss Drug, Pink Slips, Says Interested Parties Doing Due Diligence (2)
- 01: Job Docket for May 1, 2009 – iBanking, UCB Pharma, Monsanto, More… (0)
April 2009 (142)
- 30: News, Money and Drugs for April 30, 2009 (0)
- 30: Biomarin’s PEG-PAL: A Closer Look and What to Expect (1)
- 30: SEQUENOM Continues Tank, Employees Suspended, Hedge Funds Sacked, Other Companies/Shareholders Suffer (0)
- 30: $6 Billion for Solvay Pharma Unit, Will Have Bids by June (3)
- 30: ARVO Starts This Weekend (0)
- 30: OSMOS Clinical Research: Conducting Clinical Trials in Europe Just Got Easier, More Effective (0)
- 30: Job Docket for April 30, 2009 (0)
- 29: More Dendreon: “monthaphumchareon” Prediction Deleted, No More Comments from Nasdaq or DNDN (1)
- 29: News, Money and Drugs for April 29, 2009 (0)
- 29: SEQUENOM Crashes, Burns After Hours! Says Employees “Mishandled” Data, Down Syndrome Test Delayed! (0)
- 29: We Called It: Zymogenetics Axes 161!! (2)
- 29: Today’s Rumor: Vertex Acquisition, Stock Settling Down (0)
- 29: Job Docket for April 29, 2009 (0)
- 29: Innovation in Drug Discovery and Development, Biovays Leads the Way in Biotech CROs (0)
- 28: News, Money and Drugs for April 28, 2009 (0)
- 28: Dendreon Update: Stock Back Up After-Hours, More Fortunes Made/Lost! (1)
- 28: Dendreon Reveals Data, NASDAQ Investigation Timeline, Fortunes Lost/Made! (2)
- 28: Biotech Funds: NEA Gets Extra $1B, VenturEast Life Beefs Up (0)
- 28: DNDN Update, Stock Down 40% Ahead of Presentation!!! (0)
- 28: Ranbaxy Ready to Cut Jobs in Europe (0)
- 28: Italy’s BioXell Swings Axe, 14 Employees Out, Pain Antibody Now Focus (0)
- 28: Ardea Biosciences in $400M Deal with Bayer, $35M Upfront (0)
- 28: Dendreon Presenting Today at AUA (0)
- 28: Job Docket for April 28, 2009 (2)
- 27: News, Money and Drugs for April 27, 2009 (0)
- 27: Time Magazine Results: Pfizer’s Jeff Kindler LEAST Influential, Comes in DEAD LAST!!! (0)
- 27: Midday Trials Update: Biolex Presents HCV Data, Xenoport Tumbles, Nexavar Fails (0)
- 27: American Academy of Neurology Update, Cladribine in Trouble? (0)
- 27: Recent Financings: Pharmos, Alethia Biotherapeutics (1)
- 27: Job Docket for April 27, 2009 (0)
- 26: Last Week’s Top Ten: Jeff Kindler in Time Magazine, Pixantrone, Solvay Rumors and ASCO Watch (0)
- 24: Biotech/Pharma Layoffs – Who’s Gone Next Week? (0)
- 24: Jerini Ophthalmic Done!! No Buyers! (1)
- 24: Job Docket for April 24, 2009 (0)
- 23: Arena Pharmaceuticals Shows 130 Employees The Exit Sign (SEC Filing Cites “Disposal Activities”) (5)
- 23: News, Money and Drugs for April 23, 2009 (0)
- 23: SEQUENOM Says See-Ya to 30 Employees (0)
- 23: Venture Update: Addrenex Pharmaceuticals (Sciele Shopping Hypertension?) (0)
- 23: ASCO Watch 09: Genta, Exelixis, Roche/Genentech, Cell Therapeutics (2)
- 23: Job Docket for April 23, 2009 (0)
- 22: News, Money and Drugs for April 22, 2009 (0)
- 22: Dear Carl Icahn…Sincerely, IguanaBio (1)
- 22: Almost Confirmed: Somaxon Dead, CFO, BizDev, QA Positions Axed! (0)
- 22: Solvay Sends Email to Employees, Confirms “Consultants” and Evaluation of “Strategic Options” (0)
- 22: Avastin Trial Fails, Bum Deal for Roche, Great for Genentech Shareholders, Not All Bad for Patients? (0)
- 22: 10% Rebate for all Biovays Service Agreements, Only Through IguanaBio! (1)
- 22: Job Docket for April 22, 2009 (0)
- 21: News, Money and Drugs for April 21, 2009 (0)
- 21: Icahn Responds, Firmly. Still Doesn’t Acknowledge Bradbury’s Existence (2)
- 21: The 1Q Top Ten Roundup: JP Morgan, Stiefel Rumors and Pussy-for-Pills (0)
- 21: Match.com for CROs and Drug Developers (3)
- 21: Venture Profile Update, Financings… (1)
- 21: Job Docket for April 21, 2009 (0)
- 20: News, Money and Drugs for April 20, 2009 (1)
- 20: Icahn to Amylin: Who’s Dan Bradbury? (0)
- 20: Pharmasset Stops Trial. Something Smells Fishy (We’re Just Sayin’ is All…) (2)
- 20: Blackstone Does it Again, Gets Nice Return on Stiefel Investment (What’s Up with the $400M Debt and Employees??) (3)
- 20: Job Docket for April 20, 2009 (0)
- 19: BREAKING: Glaxo Set to Announce Stiefel Acquisition, $3 Billion Deal (0)
- 19: Last Week’s Top Ten: Solvay Gets Ready for Buyout, Amgen Swings Axe, BiPar and that Dude from Dirty Dancing (0)
- 19: The 1Q Graveyard Roundup: CTIC Escapes, La Jolla’s Last Shot, Somaxon Death Inevitable (11)
- 19: Weekend Edition: News, Money and Drugs for April 18-19, 2009 (0)
- 18: Weekend Job Docket for April 18-19, 2009 (0)
- 18: MS Race Heating Up – What to Expect at the American Academy of Neurology (2)
- 17: Pfizer’s Jeff Kindler Nominated for Time’s 100 Most Influential (4)
- 17: Cell Therapeutics Responds to Our Pixantrone Post! (2)
- 17: Pfizer: No Layoffs in St. Louis (1)
- 17: Pharmacyclics Gets $11M Upfront From Servier (0)
- 17: Job Docket for April 17, 2009 (0)
- 16: Bioheart in Graveyard, Howard Leonhardt Working Hard! (0)
- 16: News, Money and Drugs for April 16, 2009 (0)
- 16: Chemical Spill, Explosion at Merck! (1)
- 16: Tempers People, Tempers: Vatalanib Not Enough for Patrick Swayze; BiPar – Where Did The Money Go? (1)
- 16: Actavis Sale Scrapped! Company Overvalued, Too Much Debt: Buyers (0)
- 16: Latest Financings and Deals: Santen, Synageva, Ensemble, Lycera (0)
- 16: Job Docket for April 16, 2009 (0)
- 15: News, Money and Drugs for April 15, 2009 (0)
- 15: Pixantrone: Cardiac Issues Yes or No? (5)
- 15: Dear Abbott: Bust a Move – Everyone’s Waiting… (1)
- 15: Infinity Pharmaceuticals Crashes, But Not That Much…Karma? (1)
- 15: Sanofi “Buys” BiPar for $500M…Sanofi Crazy, BiPar Lucky? (5)
- 15: Biovays – Innovation in Preclinical Development (0)
- 15: Job Docket for April 15, 2009 (0)
- 14: News, Money and Drugs for April 14, 2009 (0)
- 14: Al Gore Worked Up Over Stem Cell Company iZUMI Bio, FORMAC Gets $2.8M (1)
- 14: Confirmed: Abbott or Sanofi Will Buy Solvay Pharma Unit; Rumor: Rothschild Preparing to Axe Solvay Reps (2)
- 14: Uh-Oh, Patient on Novartis’ MS Drug FTY720 Gets Hemorrhaging Focal Encephalitis (0)
- 14: BREAKING: Dendreon’s Provenge Meets Primary Endpoint!! (0)
- 14: Job Docket for April 14, 2009 (0)
- 13: News, Money and Drugs for April 13, 2009 (1)
- 13: Financings Abound: Marinus Pharmaceuticals, Piedmont, NeoStem… (0)
- 13: Dendreon Data To Be Released Tomorrow at 9AM EST! (0)
- 13: Company Updates: Serentis and Deciphera (0)
- 13: Employees Get Boot: J&J, Amgen, Cleveland BioLabs (0)
- 13: Job Docket for April 13, 2009 (0)
- 12: The Top Ten – Zymo Axes, Farrah Fawcett, CTIC and Howard Leonhardt’s Swingin’ Pad (0)
- 09: Holiday Notice! (0)
- 09: Italy’s BioXell: Failed Lead, Scrapped Pipeline, Tons of Cash (0)
- 09: Merck/Cardiome Deal: $60M Upfront for Vernakalant (0)
- 09: Job Docket for April 9, 2009 (2)
- 08: News, Money and Drugs for April 8, 2009 (1)
- 08: Somaxon Gets FDA Blow, Will Mine Data…But We Know They Know (1)
- 08: Today’s Rumor: Endo Axes 100+ Employees (0)
- 08: DiObex Folds, 902 Raises Liver Enzymes, Glucagon Overvalued, All Employees Axed (0)
- 08: Serentis Accelerating its Dermatology Assets (0)
- 08: Biovays CRO Model a Success at Discovery Summit 09 (0)
- 08: Job Docket for April 8, 2009 (0)
- 07: News, Money and Drugs for April 7, 2009 (0)
- 07: Financing Roundup: Aerovance, KeyNeurotek (0)
- 07: Psilos Group vs. Economy, Plans to Raise $450M Fund (0)
- 07: Novartis Swinging Axe in U.S., Focus on China (0)
- 07: Venture Updates: Trius Therapeutics, Trophos, Mithridion (0)
- 07: Job Docket for April 7, 2009 (0)
- 06: News, Money and Drugs for April 6, 2009 (0)
- 06: Facet Biotech Responds to Analyst (F*@! Off!!) (0)
- 06: OMG! Bioheart CEO’s Pad Rocks – Tennis Court n’ All!!! (0)
- 06: Layoff Rumors: GSK, Zymogenetics (1)
- 06: Novo Nordisk: Amylin, Pesky Thyroid Experts and that Damn Caribbean Cruise (0)
- 06: Job Docket for April 6, 2009 (0)
- 05: Weekend Edition: News, Money and Drugs for April 4-5, 2009 (0)
- 05: Last Week’s Top Ten: Patrick Swayze Dethroned, Zohar Hanging On, Pussy-for-Pills Out, Acorda Screws Up! (0)
- 05: Farrah Fawcett on Deathbed, Help From AmReGen Biopharmaceuticals? (0)
- 04: Weekend Job Docket for April 4-5, 2009 – Roche, Bayer, Onyx (0)
- 04: Companies: On the Brink vs. The Strong (0)
- 03: Dendreon Causing Stir Again (0)
- 03: Shire Pharmaceuticals Axes 260 from Manufacturing (1)
- 03: Job Docket for April 3, 2009 (0)
- 02: Cell Therapeutics, Pixantrone – Status? (3)
- 02: News, Money and Drugs for April 2, 2009 (0)
- 02: Breaking…Novo’s Liraglutide Dead: FDA Panel (2)
- 02: More Stiefel: Maybe Not on the Auction Block After All… (1)
- 02: Today’s Rumor: Forest Labs Buyout (0)
- 02: Investors vs. Management: Icahn, Facet Biotech, Icagen (0)
- 02: Job Docket for Thursday, April 2, 2009 (0)
- 01: CORRECTION: Acorda Therapeutics: Somebody F@!*ed Up, Big Time… (0)
- 01: News, Money and Drugs for Wednesday, April 1, 2009 (Pfizer-Wyeth Deal Scrapped!!!) (0)
- 01: Panel Backs Astra’s, BMS’ Saxagliptin 10-2 (0)
- 01: Today’s Rumors: More Allergan, Bayer Oncology Layoffs (0)
- 01: More Pfizer: Kindler Emerges from Shadows (0)
- 01: TorreyPines Down to Three Employees; Graveyard in Sight (0)
- 01: Biovays – Personalized Medicine Meets Preclinical Development (0)
- 01: Job Docket for Wednesday, April 1, 2009 – Takeda, Astellas, Vertex (0)
March 2009 (172)
- 31: News, Money and Drugs for Tuesday, March 31, 2009 (Plus More ACC) (0)
- 31: Acorda Therapeutics: Somebody F@!*ed Up, Big Time… (4)
- 31: Genzyme in the News: Bayer Deal, Failed Gene Therapy Trial (3)
- 31: Avastin for Brain Cancer: 10-0 (0)
- 31: With $391 in Sales in 08, Symbollon Enters Graveyard (1)
- 31: Novo, Acorda Hit Roadblocks (0)
- 31: Job Docket for Tuesday, March 31, 2009 – Dow, Beckman, Consulting (0)
- 30: Money Here, Money There: Today’s Financings & Deals (0)
- 30: News, Money and Drugs for Monday, March 30, 2009 (Plus ACC Roundup) (0)
- 30: Osiris Axes 80 Employees (0)
- 30: Days After Complete Response, Dyax Fires 60 Employees (0)
- 30: More on Patrick Swayze and Vatalanib – Status? (0)
- 30: Axe Swings: GenVec, Genaera, Adherex; Isolagen in Graveyard (0)
- 30: Essex Woodlands Raises $900M Healthcare Fund (0)
- 30: Job Docket for Monday, March 30, 2009 – EMD Serono, Toxikon, Johnson & Johnson (0)
- 29: It’s That Time Again: Last Week’s Top Ten!!! (0)
- 29: Weekend News Roundup – March 28-29, 2009 (0)
- 28: Weekend Job Docket for March 28-29, 2009 – Valeant, Genzyme, Roche (0)
- 27: Osiris Stops Trial, Stock Tanks, What Went Wrong? We Know… (0)
- 27: Evotec Has Plan, Slashes 50 Jobs (0)
- 27: Job Docket for Friday, March 27, 2009 – MedImmune, Genzyme, Vertex (0)
- 26: ObamaDrama and Biogenerics, VCs; Plus, “No Gifts For You!” (3)
- 26: News, Money and Drugs for Thursday, March 26, 2009 (0)
- 26: Financings Finally – Reata, Neuraltus, VaxInnate (0)
- 26: InSite Vision Sacks Half of Workforce (0)
- 26: Exec Pitches “Me-Too” at Oyster Shack (0)
- 26: Today’s Rumor: Lundbeck Buying Elan (0)
- 26: More Companies on the Brink, Welcome to The Graveyard! (0)
- 26: Job Docket for Thursday, March 26, 2009 – Astellas, Takeda, Novartis (0)
- 25: News, Money and Drugs – Wednesday, March 25, 2009 (0)
- 25: More Homes of the Pharma Stars… (0)
- 25: Advil Aint’ Cuttin’ It, SCOLR Board Members Get Boot (0)
- 25: Oscient in Graveyard, May Not be Buried (Sadly) (1)
- 25: More KV Jobs in the Krapper (0)
- 25: Venture Capital Failing, Start-ups Suffer, Publics Near Death (0)
- 25: Getting That Perfect Drug Into Clinical Trials (1)
- 25: Job Docket for Wednesday, March 25, 2009 – Syngenta, Envision, Serono (0)
- 24: Cell Therapeutics: Not Down, Not Out… (0)
- 24: The Other Gardasil (1)
- 24: Triciribine: One Man’s Trash, Another Man’s Treasure (1)
- 24: Allergan Buyout Rumor Fueled Again, Stock Skyrocketing (0)
- 24: 1,450 Pink Slips at Hospira (0)
- 24: Job Docket for Monday, March 24, 2009 – Abbott, ISIS, Serono (0)
- 23: News, Money and Drugs – Monday, March 23, 2009 (0)
- 23: For Sale: Nycomed (0)
- 23: Today’s Rumor: Allergan on Auction Block (0)
- 23: Plan B for Kids: FDA Slapped, High School Seniors Rejoice (2)
- 23: ConjuChem: Our Drug Worked, You’re Fired (0)
- 23: Yet Another Fund: 5AM Raises $119M (1)
- 23: Merck Serono Starts $54M Venture Group (0)
- 23: Job Docket for Monday, March 20, 2009 – Infinity, Stem Cells, Tepnel (0)
- 22: Top Stories for the Week of March 15-21, 2009…Daphne Zohar, Astra’s Pussy-for-Pills and Patrick Swayze (Again) (1)
- 21: 7PM and Already Buzzin’…Louis Lange and CVTX: I’m Sorry Bro (1)
- 21: Weekend Job Docket – It Just Might Come to This (1)
- 20: News, Money and Drugs – Friday, March 20, 2009 (1)
- 20: R.I.P. ADVENTRX Pharmaceuticals (2)
- 20: Poniard Hands Out Pink Slips, Bets on Picoplatin (0)
- 20: Pfizer to (Eventually) Axe ALL Reps (3)
- 20: Stiefel on Auction Block (1)
- 20: Job Docket for Friday, March 20, 2009 – Millennium, Battelle, Envision (0)
- 19: More Madoff: Upsher-Smith Employees, Owner Hurt (7)
- 19: Hey! Daphne Zohar’s Follica on FoxNews! (2)
- 19: Astra’s Pussy-for-Pills Makes Gawker (1)
- 19: Low on Cash, Cortex Cuts 50% of Workforce (0)
- 19: Job Docket for Thursday, March 19, 2009 – Vertex, MedImmune, Beckman (0)
- 19: Buyout Rumors: Pfizer Buying Ratiopharm? (1)
- 18: News, Money and Drugs – Wednesday, March 18, 2009 (0)
- 18: Bernie Madoff and Biotech – What’s at Stake? (0)
- 18: Multaq on Way to Blockbuster Status (0)
- 18: Cerus Swings Axe (0)
- 18: Today’s Rumor: Pixantrone Deal Coming? (0)
- 18: Biovays – Biomarkers for Targeted Drug Leads (0)
- 18: Job Docket for March 18, 2009 – EMD Serono, Elan, Novartis (0)
- 17: Uh-Oh, Roche/Chugai Drug Kills Patients (0)
- 17: News, Money and Drugs – Tuesday, March 17, 2009 (0)
- 17: Update from Cowen: What Do the Docs Think? (0)
- 17: J&J and Disney – Exploring Soap Opera 2.0 (0)
- 17: AstraZeneca: Next Round of Employees Shown the Exit (0)
- 17: Kindler Defends Dividend Cut to Shareholders (0)
- 17: Cytos Vaccine Fails, Pink Slips Abound (0)
- 17: Job Docket for March 17, 2009 – Happy St. Patrick’s Day!!! (0)
- 16: Today’s Financings and Deals: Innovatis, NKT Therapeutics, SFJ Pharma (0)
- 16: News, Money and Drugs – Monday, March 16, 2009 (0)
- 16: End of the Line for Cell Therapeutics (2)
- 16: Synta: Behind the Scenes. Look Sad? (0)
- 16: Mead Johnson – The Final Damage (0)
- 16: Latest Layoffs – Bellus, Roche, Synta (0)
- 16: Job Docket for March 16, 2009 – MedImmune, Dow, Beckman… (0)
- 15: Last Week’s Top 10!!! (0)
- 15: Weekend Job Docket for March 14-15, 2009 (0)
- 13: Fresh IPO, Mead Johnson Set to Swing Axe (0)
- 13: More Money: Kenta, Sangart, Relypsa, Endeavour Capital (0)
- 13: Job Docket for March 13, 2009 – Novartis, Cubist, AAI… (0)
- 12: News, Money and Drugs – Thursday, March 12, 2009 (0)
- 12: Cadence Drug Dead, Ready to Can (0)
- 12: $100M in Debt and Low Cash, EPIX Hands Out Walking Papers (0)
- 12: More Safety Concerns with Amgen’s Denosumab? (0)
- 12: Gilead Offers to Buy CV Therapeutics for $20/Share!!! (0)
- 12: DONE DEAL!!! (0)
- 12: Job Docket for March 12, 2009 – Syngenta, Devices, Patents… (0)
- 11: Who’s Getting Financed This Week… (0)
- 11: News, Money and Drugs – Wednesday, March 11, 2009 (0)
- 11: Novo Nordisk Cruise (Spring Break) 2009 Underway! (0)
- 11: MedImmune D-Day is… (0)
- 11: Uh-oh, Geron Skeptic and Roche/DNA Snag… (0)
- 11: Biovays – Innovation in Preclinical Development (1)
- 11: Job Docket for March 11, 2009 – Dow Chemical, Vertex, VWR, More… (0)
- 10: News, Money and Drugs – Tuesday, March 10, 2009 (0)
- 10: Roche/DNA – Can We Consummate This Thing Already? (0)
- 10: Pharma M&A from The Lawyer’s Eye; Also, Orbimed Speaks (0)
- 10: Pappas Pulls in $102M (0)
- 10: Worst CEO of 2007 Makes Nice in 2008 (3)
- 10: Kindler Can’t Face Reps? (0)
- 10: Job Docket for March 9, 2009 – Syngenta, Medtronic and Consulting… (0)
- 09: More Sanofi: Layoffs Coming (0)
- 09: News, Money and Drugs – Monday, March 9, 2009 (0)
- 09: UPDATED: WSJ Reporting Roche/DNA Deal Close (0)
- 09: WSJ Reporting Roche/DNA Deal Close (0)
- 09: More Buyout Rumors: Sanofi/BMS, Roche/DNA and J&J/Eisai (0)
- 09: Merck and Schering-Plough Deal = 15,000 Jobs Gone!!! (0)
- 09: Job Docket for March 9, 2009 – Millennium, Medtronic, Stanford, (0)
- 09: UPDATED: Merck and Schering-Plough Merging in $41B Deal! (1)
- 09: Merck and Schering-Plough Merging in $41B Deal! (0)
- 07: What Floats Your Boat? This Week’s Top 10 Stories (1)
- 06: SPAC in the Graveyard; CTIC, Northfield Can Workers (0)
- 06: News, Money and Drugs – Friday, March 6, 2009 (0)
- 06: Rumor and Proof: Sanofi Ready to Swing Axe (0)
- 06: UPDATED: Roche Upping DNA Offer to $93… (2)
- 06: Roche Upping DNA Offer to $93… (0)
- 06: OPKO’s siRNA Drug Fails in Phase 3! Phil Frost Speaks! (0)
- 06: Astellas: Louis Lange’s Days Numbered (0)
- 06: Job Docket for March 6, 2009 – Shire, Ista, Genzyme, More… (0)
- 05: Eli Lilly: Oh Man, It’s Good To Be Sidney Taurel (2)
- 05: Jeff Kindler’s Contact Info — Is This Real? (Updated) (5)
- 05: News, Money and Drugs – Thursday, March 5, 2009 (0)
- 05: Bad Day For Markets, Pharma (0)
- 05: More on Jeff Kindler’s Contact Info — Email Valid (1)
- 05: SkyePharma Workers (in France) Dust Off Resumes (0)
- 05: Heidi Klum and Amgen? (0)
- 05: Some Big Deals Overnight – Proteon and BMS (0)
- 05: Bradmer Cans Workers and Patients…I know, I know – Who’s Bradmer? (0)
- 05: CombinatoRx Confirms: 30 Workers Axed (0)
- 05: Buy When Stevie Cohen Sells? (0)
- 05: Morning Job Docket – Thursday, March 5, 2009 (0)
- 04: Daily Roundup – Wednesday, March 4, 2009 (0)
- 04: Index Ventures: Don’t Get Too Excited. Venrock, OK (0)
- 04: Legal: Wyeth Whines, Patents, French at War!, Pfizer Pays (0)
- 04: Today’s Rumor: MedImmune Swinging Axe! (0)
- 04: What Does Cramer Think? (3)
- 04: Amylin Board Meeting Yesterday – Fly on The Wall (0)
- 04: Procter & Gamble CEO Lafley – Livin’ Large! (0)
- 04: Overnight – ViroChem Acquired, Acusphere Swings Axe (0)
- 04: Morning Job Docket – Wednesday, March 4, 2009 (0)
- 03: Daily Roundup – Tuesday, March 3, 2009 (0)
- 03: KV Shows 310 (More) Employees the Exit. Did We Miss Something? (0)
- 03: Today’s Rumor: Blackstone Loss Equals Stiefel Cuts (0)
- 03: Wow! Even Patients Are Getting a Pink Slip! (0)
- 03: Pfizer Deals Were Floating Around Online Yesterday… (1)
- 03: Genzyme Waited 3 Days??!! WTF??!! (0)
- 03: Sex for the (Elderly) Ladies: P&G’s Testosterone a Dud (0)
- 03: UCB Confirms: 2000 Pink Slips (1)
- 03: Inspire Tries on Boot, 20 Out The Door (0)
- 03: Morning Job Docket – Tuesday, March 3, 2009 (1)
- 02: Our New Site is Coming Soon… (0)
- 02: Daily Roundup – Monday, March 2, 2009 (0)
- 02: Banks, VC Funds Not Dead (0)
- 02: Synta Not Alone in Failure, Maybe Not Dead (1)
- 02: Targeted Genetics Warns Layoff Cliff Ahead (4)
- 02: Today’s Rumor: Fired from Pfizer Not That Bad (0)
- 02: Dear Bioheart, Get Out! (0)
- 02: Morning Job Docket – Monday, March 2, 2009 (0)
- 01: We’re Back!!!! (0)
February 2009 (138)
- 27: We’ll Be Back on Sunday, and Breaking News for Friday (0)
- 27: Morning Job Docket – Friday, February 27, 2009 (0)
- 26: Daiichi Sankyo – Slumdog Stock (0)
- 26: Daily Roundup – Thursday, February 26, 2009 (0)
- 26: Oh No, Synta Crashes!!! “O” Face for Elesclomol Gone! (0)
- 26: Legal Nightmares – Pfizer, Patents, Follow-Ons, Forest F-s up (0)
- 26: ImClone Inside Trader: LabRat, It’s a Good Thing? (0)
- 26: King Pharmaceuticals Kraps in Q4 (0)
- 26: Morning Job Docket – Thursday, February 26, 2009 (0)
- 25: Abbott: Good Deals, Great Stock, Awesome Mansion! (0)
- 25: Daily Roundup – Wednesday, February 25, 2009 (0)
- 25: Trubion Employee Worth About $32,000 (0)
- 25: J&J, ALZA Show No Mercy; 140 Workers Out the Door (0)
- 25: Worst CEO of 07 Makes $5M in One Day (1)
- 25: Fantasy Pharma – Place Your Bets (2)
- 25: Lawsuit Spooks Histogen Investors, Employees Axed (0)
- 25: This Company is NOT LAYING OFF (0)
- 25: Elan Tries on Boot, 230 Out the Door!! (0)
- 25: Morning Job Docket – Wednesday, February 25, 2009 (0)
- 25: Yahoo!Zacks – Acorda Rating Too Little Too Late? (0)
- 24: Novartis Hostage Crisis – Names Released (0)
- 24: Daily Roundup – Tuesday, February 24, 2009 (0)
- 24: Dynogen Dead, Welcome to The Graveyard (2)
- 24: Biogen Wants Fampridine, Acorda Up 30% (0)
- 24: Elan PO’ed at Media, Gloves Coming Off (0)
- 24: More Layoffs: Celera, Enzon, Response Genetics (0)
- 24: MAP Pharmaceuticals Fails!!! Graveyard in Sight? (0)
- 24: Morning Job Docket – Tuesday, February 24, 2009 (0)
- 23: Merck Cans 750!! (0)
- 23: Daily Roundup – Monday, February 23, 2009 (0)
- 23: Panacos Near Death, Ghost of Former Self (0)
- 23: Pacira Passes Out Pink Slips (0)
- 23: Astellas Attacks Back; CV Crazy? (0)
- 23: Kindler Speaks! Teva Does Too… (0)
- 23: Pfizer Legal Woes – Porn, Car Accidents, John Roberts and Fraud (0)
- 23: No Cash and Failed Drug, Intercytex Goes Belly Up (0)
- 23: Big Macs Make Good Big Pharma Ties (2)
- 23: Morning Job Docket – Monday, February 23, 2009 (0)
- 20: Cafepharma Was Right: Daiichi Sankyo Swinging Axe (0)
- 20: Homes of the (Pharma) Stars: Today, GSK’s Andrew Witty (0)
- 20: Astellas Rejected! (0)
- 20: Morning Job Docket – Friday, February 20, 2009 (0)
- 19: Daily Roundup – Thursday, February 19, 2009 (0)
- 19: La Jolla in Graveyard, Jobs in Coffin, Burial Soon… (0)
- 19: Phytopharm Done With Hoodia, Done With Employees (0)
- 19: Sweden’s Medivir Ready to Axe Its Own (0)
- 19: Today’s House: Phil Frost – This Guy’s Pad Destroys All Others (0)
- 19: Morning Job Docket – Thursday, February 19, 2009 (0)
- 18: Daily Roundup – Wednesday, February 18, 2009 (0)
- 18: Did Vatalanib Work for Patrick Swayze? (12)
- 18: Kythera Brings in Additional $10M for Deoxycholate (0)
- 18: What Happened to All of Our Company Profiles?! (0)
- 18: Buffett Drops Johnson & Johnson, P&G (0)
- 18: Remember Jones Pharma? Check out These Pads… (1)
- 18: Roth Capital Over Today (0)
- 18: Morning Job Docket – Wednesday, February 18, 2009 (0)
- 18: Thanks to Our Supporters (0)
- 17: Daily Roundup – Tuesday 02.17.09 (0)
- 17: More Pfizer, Kilts’ House Rocks (1)
- 17: Ratiopharm Axes 600 as Company Seeks Buyers (0)
- 17: This is Crazy!! Elan Board Ready to Cash Out! (0)
- 17: Michigan Biotechs Might Be Saved, New Fund Closes (0)
- 17: Morning Job Docket – Tuesday, February 17, 2009 (0)
- 16: Happy President’s Day!!! We’ll Be Back Tomorrow… (0)
- 15: Weekend Job Docket – February 14-15, 2009 (0)
- 14: Australia’s Novogen Axes 11 People, Huh? (1)
- 13: Haemacure Bites Dust, Puts Up For Sale Sign (0)
- 13: Morning Job Docket – Friday, February 13, 2009 (0)
- 12: Biotech Financings Galore… (0)
- 12: The Axe Swings at Alcon – 260 Gone! (0)
- 12: Oscient – The Big “O” (0)
- 12: More Pfizer, Kindler’s Pad Not All That (0)
- 12: Deals and Failures!!! Portola, Insmed, Riquent and DOR (0)
- 12: Morning Job Docket – Thursday, February 12, 2009 (0)
- 11: Daily Roundup – Wednesday 02.11.09 (0)
- 11: “Reorganization” at Telik, 42 Employees Axed (0)
- 11: More Layoffs at Amgen (0)
- 11: Layoffs – Ten Researchers Worth About $1,060,000 (0)
- 11: Morning Job Docket – Wednesday, 02-11-09 (0)
- 11: Start-Up Capital, Pharma Jobs, CROs and Diagnostics (0)
- 10: Daily Roundup – Tuesday 02.10.09 (0)
- 10: The Man Who Saved the Ten-Second (European) Man (0)
- 10: Elan Crabtree Letters, Jack Loves Kelly (0)
- 10: Bayer Already Screwing Up Yaz Promotion (0)
- 10: BioPartnering North America Almost Over (1)
- 10: BIO CEO – Cell Therapeutics (CTIC) Notes (0)
- 10: Irish Green – Seroba Kernel Raises $100M for New Fund (0)
- 10: Morning Job Docket – Tuesday, 02-10-09 (0)
- 09: Daily Roundup – Monday 02.09.09 (0)
- 09: BIO CEO 2009, Part 7: T-Z (The End and Coverage Updates) (0)
- 09: BIO CEO – Celgene Notes (0)
- 09: KV Kans 700! (0)
- 09: BIO CEO – Cyclacel Notes (0)
- 09: BIO CEO – Acorda Notes (0)
- 09: Ovation Pharmaceuticals Sold to Lundbeck for $900M!!! (0)
- 09: Morning Job Docket – Monday, February 9, 2009 (0)
- 08: BIO CEO 2009, Part 6: O-S (Tomorrow’s the Big Day) (0)
- 08: Audience Stats – Where Are You? (0)
- 07: BIO CEO 2009, Part 5: I-N (Let’s See What the Cat Dragged In) (0)
- 07: Weekend Job Docket – Saturday, February 7, 2009 (0)
- 06: BIO CEO 2009 – Who We’ll Be Covering (1)
- 06: Daily Roundup – Friday 02.06.09 (0)
- 06: More From Pfizer, Kindler (1)
- 06: GSK Reportedly Going After Piramal for $1.5 Billion (0)
- 06: The JLo of Glaxo, 3 Days Until D-Day (0)
- 06: BIO CEO 2009, Part 4: E-H (Tempers People, Tempers) (3)
- 06: Recent Financings: Drugs vs. Diagnostics (0)
- 06: France (Biotech) Needs Help! (0)
- 06: Morning Job Docket – Friday, February 6, 2009 (0)
- 05: Daily Roundup – Thursday 02.05.09 (0)
- 05: Layoffs at Medicis? (0)
- 05: Latest Video: Boston Biotech, Cramer & Allergan, BioMS (0)
- 05: Morning Job Docket – Thursday, February 5, 2009 (0)
- 04: Daily Roundup – Wednesday 02.04.09 (0)
- 04: BIO CEO 2009, Part 3: The B’s-D’s (6)
- 04: Work in Cali? Who’s Next to Get Canned? (0)
- 04: No Biotech Job? Try Devices (0)
- 04: Allergan Lays Off 460!!! (0)
- 04: Helica Biosystems, PharmaTalentPool and Biovays (0)
- 04: Morning Job Docket – Wednesday, February 4, 2009 (0)
- 03: Late Stock Notes: Allos, Array (0)
- 03: Hey! Is Your Company Hiring? (0)
- 03: Daily Roundup – Tuesday 02.03.09 (0)
- 03: Clinuvel Video Clip from Down Under – Need a Tan? (1)
- 03: This Guy is Going After Harvard Docs (0)
- 03: The “Other” BIO CEO, Part 1 (2)
- 03: King, Rigel Try on “Reorganization” Boot (0)
- 03: Morning Job Docket – Tuesday, February 3, 2009 (0)
- 02: BIO CEO 2009, Part 2: The A’s (2)
- 02: Daily Roundup – Monday 02.02.09 (1)
- 02: Layoffs at Hollis-Eden (0)
- 02: Who’s Getting Paid: The Week in Deals (0)
- 02: Kindler on CNBC – You Gotta See This! (0)
- 02: Sanofi Has $5B in the Bank… (0)
- 02: Alexza, ICOS Flush Jobs Down Toilet (0)
- 02: Atlas Ventures Closes $283M Fund… (1)
- 02: GSK Next to Try on Boot, Kicks 6,000 Out the Door (0)
- 02: Morning Job Docket – Monday, February 2, 2009 (0)
January 2009 (171)
- 30: We’ll Be Back on Monday, Maybe Sunday! (0)
- 30: Isotechnika (who?) Is Struggling Too… (0)
- 29: BIO CEO, Part 1: Right Around the Corner (2)
- 29: AstraZeneca Eliminating 15,000 Jobs! (0)
- 29: Morning Job Docket – Thursday, January 29, 2009 (0)
- 28: Daily Roundup – Wednesday 01.28.09 (0)
- 28: Sepracor Tries on “Restructuring” Boot – Cans 1000! (0)
- 28: Dear Wyeth Employees, Don’t Contact Pfizer! (3)
- 28: Abbott Cans 200 Sales Reps (1)
- 28: Healthcare Hedge Funds in 2008 – Who Are They? (0)
- 28: ‘Hills’ Starlet Promoting Birth Control Pill ‘Yaz’ (2)
- 28: Diagnostics, Pharma Jobs and a Great CRO… (0)
- 28: Morning Job Docket – Wednesday, January 28, 2009 (0)
- 27: Trophos – Tough Luck for Ten Years (0)
- 27: Daily Roundup – Tuesday 01.27.09 (1)
- 27: After Playing Hard to Get, NitroMed Gives In (0)
- 27: Life Science VCs – Where Are the Ladies? (0)
- 27: Acucela – Dry Eye and Dry AMD (1)
- 27: Astellas Trying to Buy CV Therapeutics (0)
- 27: Morning Job Docket – Tuesday 01.27.09 (0)
- 26: Proof-of-Concept: Don’t Believe What You Read (0)
- 26: Daily Roundup – Monday 01.26.09 (2)
- 26: Start-Up Updates: Trius, Selexys (0)
- 26: Salary Surveys and Layoff Stories (3)
- 26: Uh-Oh, Merck’s MS Drug Already in Trouble? (0)
- 26: BiPar Sciences – Bye Bye Soon? (0)
- 26: Altus Pharmaceuticals Scraps 100+ Employees (0)
- 26: Pfizer/Wyeth Merge; 8000 Jobs Gone!!! Crucell Deal Out! (0)
- 26: Morning Job Docket – Monday, January 26, 2009 (0)
- 26: ProteoTech – Amazonian in Nature (0)
- 25: Bad Times but Med Profs Still Want In… (0)
- 25: Weekend Job Docket – January 24-25, 2009 (0)
- 24: Saturday Night Quickie: Mad Money, Zingo and the FDA (3)
- 23: More Companies Try on “Das Boot,” One Hires (8)
- 23: Daily Roundup – Friday, January 23, 2009 (4)
- 23: Deciphera Pharmaceuticals – Deciphering Kinases (0)
- 23: Oxagen – Out of Allergies? (0)
- 23: More Pfizer/Wyeth Stuff (0)
- 23: Pfizer Buying Wyeth (0)
- 23: Morning Job Docket – Friday, January 23, 2009 (0)
- 22: Daily Roundup – Thursday, January 22, 2009 (2)
- 22: Biotech: Which Way is the Exit? (0)
- 22: Mithridion – Midwest Merger, Memory Mayhem (0)
- 22: We Couldn’t Go Just One Day, Could We? (0)
- 22: No More Pharma Gifts? A Personal Story… (1)
- 22: NicOx Buyout Flying Under the Radar (0)
- 22: Morning Job Docket – Thursday, January 22, 2009 (0)
- 21: Who’s Getting Paid? (2)
- 21: Daily Roundup – Wednesday, January 21, 2009 (3)
- 21: Follica – Fooling Around with Baldness (0)
- 21: Tragara Pharmaceuticals – Tricky COX-2 (0)
- 21: Good Drug, Dead Drug… (0)
- 21: EU Life Science Ventures Are Pounding the US (0)
- 21: Great Pharma Talent and Innovative Diagnostics… (0)
- 21: Morning BioJob Docket – Wednesday, January 21, 2009 (0)
- 20: Salsalate for Diabetics – Don’t Drink the Kool-Aid (0)
- 20: Daily Roundup – Tuesday, January 20, 2009 (0)
- 20: Danube Pharmaceuticals – Diving into Glaucoma (0)
- 20: Synosia Therapeutics – Roche Pipeline Divested (0)
- 20: Wow! Pfizer’s New Ad is Weird! (1)
- 20: More Pink Slips (0)
- 20: Morning BioJob Docket – Tuesday, January 20, 2009 (0)
- 19: Late Notes – Actelion JPM (6)
- 19: Yeah, We’re Off Today, But We’re Hearing $110-130 for DNA (0)
- 19: We’ll Be Back Tomorrow! (0)
- 19: Morning BioJob Docket – Monday, January 19, 2009 (0)
- 19: IguanaBio Readers – Who Are You? (3)
- 18: Weekend Roundup – January 17-18, 2009 (2)
- 18: There’s Money in Drug Pushing. I Knew It! (1)
- 17: Alexion Notes from JPM (0)
- 17: Alcon Notes from JPM (0)
- 17: BioMarin Notes From JPM (0)
- 16: This is the US, Can We Have Some $$$ Too? (0)
- 16: Nuon Therapeutics – Tranilast Noted (0)
- 16: Well Hello! Welcome to Bioheart. You’re fired! (0)
- 16: Daily Roundup – Friday, January 16, 2009 (0)
- 16: Does Pfizer Need a Bailout Too? (0)
- 16: Biolex Therapeutics – Bring on the Duckweed (0)
- 16: Morning BioJob Docket – Friday, January 16, 2009 (1)
- 15: JP Morgan is Over. We’ll be Back Tomorrow with New Company Profiles (0)
- 15: Xenoport Slides from JPM (0)
- 15: Wow! Pfizer Cutting 1/3 of Sales Force (0)
- 15: Obagi Medical Products – Notes From JPM (0)
- 15: Daily Roundup – Thursday, January 15, 2009 (0)
- 15: XOMA Says “See Ya” to 144 Employees (0)
- 15: JPM Notes: Facet Biotech (0)
- 15: BioNovo Also Says “Adios” to Employees (1)
- 15: Roche Next to Try on Boot, Cuts 780 Jobs (0)
- 15: Cafepharma: Novartis Head Honcho is Watching You (0)
- 15: Morning BioJob Docket – Thursday, January 15, 2009 (0)
- 14: JPM Reviews Coming This Weekend (0)
- 14: JPM – Biovitrum (0)
- 14: Thanks to Helica Biosystems (0)
- 14: Stromedix – Born in Biogen (0)
- 14: Daily Roundup – Wednesday, January 14, 2009 (0)
- 14: Stevie Cohen Dumps Indevus, BioMarin, Acorda, Savient and Inspire (0)
- 14: Arca/Nuvelo Slides from JPM (0)
- 14: Hillary Clinton Endorses Gardasil, Plan B (2)
- 14: Morning BioJob Docket – Wednesday, January 14, 2009 (0)
- 13: Thanks to All of You Out There for Visiting IguanaBio… (0)
- 13: Who We’re Covering Tomorrow… (0)
- 13: Notes from JPM Genentech Presentation (0)
- 13: Elan Presentation from JPM – Pipeline (0)
- 13: Key Pfizer Slides from JPM (0)
- 13: Nitec Pharma – Steroids at Night (0)
- 13: Aquinox Pharmaceuticals – TNF Attacker (0)
- 13: Novacta Therapeutics – Another Lantibiotic (0)
- 13: Cephalon Getting Option on Ception for $100M (0)
- 13: Layoffs at Amgen? Did We Miss Something? (2)
- 13: Daily Roundup – Tuesday, January 13, 2009 (0)
- 13: Pharmas Are Feeling Like This… (0)
- 13: Merck To Gardasil Manager: Sayonara! (0)
- 13: Biogen Pipeline Updates from JPM (0)
- 13: Pfizer D-Day is Here!!! (0)
- 13: JPM – Prism Pharmaceuticals with Slide Screenshots (0)
- 13: OMG! A Pharmaceutical Company is Actually Hiring! (0)
- 13: My Doctor Friends To The Iguana: I Told Ya So B!@*h! (1)
- 13: Morning BioJob Docket – Tuesday, January 13, 2009 (0)
- 12: Some Big Financings (and Deals) We Didn’t Get a Chance to Mention Today (1)
- 12: JPM 09 – What We’re Covering on Tuesday (0)
- 12: Seaside Therapeutics – Sention’s Fragile-X (0)
- 12: Prism Pharmaceuticals – Nexterone Next Amiodarone (0)
- 12: Acorda – Fampridine and Misc Slides from Earlier (0)
- 12: Daily Roundup – Monday, January 12, 2009 (0)
- 12: Gilead Pipeline Update Live from JPM (0)
- 12: JPM – Who’s Up Next (Afternoon Session) (0)
- 12: JPM – Amicus Most Impressive so Far (1)
- 12: Isis Pipeline Updates from JPM with Screenshots (0)
- 12: EpiCept Tries on “Restructuring” Boot, Fits (0)
- 12: Seeking Alpha Launching New Website for Healthcare Investors (0)
- 12: Parents PO’d at MTV, Don’t Endorse Teva’s Plan-B (1)
- 12: Morning BioJob Docket for Monday, January 12, 2009 (0)
- 11: Angion Biomedica – An HGF Mimetic (0)
- 11: JP Morgan Starts Tomorrow (0)
- 11: BioJobs for the Weekend of January 10-11, 2009 (0)
- 10: BioJobs for Saturday January 10, 2009 (0)
- 10: IguanaBio – Anonymous Tips, Crazy Story? (3)
- 10: Kythera Biopharmaceuticals – Double Chin? (0)
- 09: Topaz Pharmaceuticals – Topical Ivermectin (0)
- 09: It’s Wabbit Season!!! Hunter After Pharmas and Drugs (0)
- 09: Has Anyone Been Watching This? (0)
- 09: Hold on Gardasil, Just Hold on a Minute…Stick with Teen Girls for Now (1)
- 09: Array Biopharma Announces “Restructurings” – Think Chris Farley Again (0)
- 09: Jobs for Friday January 9, 2009 (0)
- 08: The Early Breaths of Biotech 3.0 – This Week’s Financings (1)
- 08: Ception Therapeutics – Promising Reslizumab (0)
- 08: Selexys – Antibodies Against P-Selectin (0)
- 08: The IguanaBio Daily Roundup – Thursday January 8, 2009 (0)
- 08: 3-Week Old Facet Biotech Gives Employees ‘da Boot – Claims “Restructuring” (0)
- 08: Aisling Capital Saving the Day! (0)
- 08: Jobs for Thursday January 8, 2009 (0)
- 07: The IguanaBio Daily Roundup (1)
- 07: More Buyout Talk (0)
- 07: More Job Axes-a-Swingin’ Amid “Restructurings” (in Chris Farley quotes) (1)
- 07: Pfizer Saved! But Definitely Not by My Old O-Chem Buddy (1)
- 07: Wednesday’s Jobs on IguanaBio (0)
- 06: Pfizer D-Day Tomorrow Jan 7th? (0)
- 06: Fen-Phen Comes Full Circle as Endo Buys Indevus (0)
- 06: DuoCort – Attacking Addison’s (0)
- 06: Wait! Abbott Also Wants to Go Shopping (1)
- 06: Jobs-a-Plenty on IguanaBio – Tuesday January 6, 2009 (1)
- 05: Teva Buying Acorda? (0)
- 05: Pharmalot is in The Graveyard (1)
- 05: HemaQuest Pharmaceuticals – Fetal Hemoglobin Upregulated! (0)
- 05: Q: What’s So Special About Synta’s Latest $1B Deal With Roche? (1)
- 05: Everyone is Making Predictions for 09 (0)
- 05: Pfizer’s Kindler Wants to Make Big Bets (0)
- 05: New Jobs on IguanaBio – Monday January 5, 2009 (0)
- 02: We’ll Be Back on January 5th! (0)
- 01: New Jobs for a Happy New Year (0)
- 01: Biotech in 2009 and Beyond – Creating Something of Lasting Value? (1)
December 2008 (47)
- 31: Happy 2009!!! (0)
- 30: Galleon Pharmaceuticals -$15M for Sleep Apnea (0)
- 30: ErgoNex Pharma – Play on PAH (0)
- 30: More BioJobs for a Food-Filled Fridge New Year! (1)
- 29: Addrenex Pharmaceuticals – Clonidine for Sciele (0)
- 29: Pfizer Reps Getting Bent Outta Shape Over Peyronie’s Deal (1)
- 29: Ready to Put Your Cash Back Into the Biotech Markets? (1)
- 29: Hot Jobs on IguanaBio (0)
- 25: Ho Ho Ho – Merry Christmas! (0)
- 23: Solace Pharmaceuticals – Straight to Proof-of-Concept (0)
- 23: Cortria Corporation – A New Niacin (0)
- 23: Biotech Hottie – Daphne Zohar (4)
- 23: Pfizer, Amgen – The Big Dawgs Are Shady (0)
- 22: Arca BioPharma – Merging with Nuvelo to Advance Bucindolol (0)
- 22: Elan CEO Voted Worst in Biotech, But Who’s the Best? (1)
- 22: Plenty of Sales Jobs on IguanaBio Job Board (0)
- 21: Elan CEO Swings Stick (0)
- 19: Good News for Biotech Entrepreneurs! There IS Light Ahead! (6)
- 19: F-ing Great – More Cans and Layoffs… (3)
- 19: Who’s Getting Paid? The Week in Deals (1)
- 18: Profile – Arcion Therapeutics (0)
- 18: Don’t Start a Start-up in 09! (1)
- 18: Cornerstone Pharmaceuticals – Cancer and Altered Energy Metabolism (0)
- 17: Amgen Being Sold to Pfizer! (5)
- 17: The Axe Swings Yet Again at Bristol Myers (1)
- 16: Biotech Job Damage for Tuesday, December 16th, 2008 (3)
- 16: Theratechnologies Gets $30M Upfront (1)
- 16: Latest Jobs on the IguanaBio Jobs Board (0)
- 16: Dollar Stretching – Latest Biotechs to Pinch Pennies (0)
- 15: More Elan – Crabtree Getting Crabby (0)
- 15: Elan Shakeup (0)
- 11: It’s Official – The Axe is Falling at Pfizer (0)
- 11: Deal of the Week – Valeant Buys Dow (0)
- 10: Layoff Numbers – The Damage So Far (1)
- 10: Biotech Bailouts! (0)
- 10: New Jobs – Biotech Lawyers Wanted (0)
- 09: Kineta – Focus on Innate Immunity and Another Cash-out, Seeking Investors (0)
- 09: Arete Therapeutics – The Future of Hypertension (0)
- 09: Today’s Deadpool – XTL (0)
- 09: Roche Rep Suing Just Days After Chief Plays Cowboy (0)
- 09: Layoffs and Cans (0)
- 08: Allos Adios? Pralatrexate Data at ASH (0)
- 08: KV CEO Kanned! (0)
- 08: The Skinny on Orexigen (1)
- 07: Boron Billions (1)
- 07: Check Out the IguanaBio Jobs Board (0)
- 07: Does Deerfield Know Something We Don’t? (0)
March 2008 (5)
- 31: Profile – Axentis Pharma AG (0)
- 31: Profile – Trius Therapeutics (0)
- 26: Limerick BioPharma/Neurosciences (0)
- 23: Profile – Amira Pharmaceuticals (0)
- 11: Profile – Mpex Pharmaceuticals (0)
February 2008 (2)
- 20: Profile – Cumbre Pharmaceuticals (0)
- 02: Profile – Cydex Pharmaceuticals (0)
January 2008 (1)
- 20: Profile – Cosmo Pharmaceuticals (0)
July 2007 (2)
May 2007 (3)
- 30: Novacea Oral Calcitriol Gets Big Break (0)
- 28: LITTLE-KNOWN AUSTRIAN ANTIBIOTIC (0)
- 27: DO WE NEED METHOXYFLURANE? (0)



